Abstract:Background Although the implication of receptor of advanced glycation endproducts (RAGE) has been reported in coronary artery disease, its roles in coronary artery ectasia (CAE) have remained undetermined. Furthermore, the effect of RAGE polymorfisms were not well-defined in scope of soluble RAGE (sRAGE) levels. Thus, we aimed to investigate the influence of the functional polymorphisms of RAGE -374T > A (rs1800624) and G82S (rs2070600) in CAE development. Methods This prospective observational study was conducted in 2 groups selected of 2452 patients who underwent elective coronary angiography (CAG) for evaluation after positive noninvasive heart tests. Group-I included 98 patients with non-obstructive coronary artery disease and CAE, and Group-II (control) included 100 patients with normal coronary arteries. SNPs were genotyped by real-time PCR using Taqman® genotyping assay. Serum sRAGE and soluble lectin-like oxidized receptor-1 (sOLR1) were assayed by ELISA and serum lipids were measured enzymatically. Results The frequencies of the RAGE -374A allele and -374AA genotype were significantly higher in CAE patients compared to controls (p < 0.001). sRAGE levels were not different between study groups, while sOLR1 levels were elevated in CAE (p = 0.004). In controls without systemic disease, -374A allele was associated with low sRAGE levels (p < 0.05), but this association was not significant in controls with HT. Similarly, sRAGE levels of CAE patients with both HT and T2DM were higher than those no systemic disease (p = 0.02). The -374A allele was also associated with younger patient age and higher platelet count in the CAE group in both total and subgroup analyses. In the correlation analyses, the -374A allele was also negatively correlated with age and positively correlated with Plt in all of these CAE groups. In the total CAE group, sRAGE levels also showed a positive correlation with age and a negative correlation with HDL-cholesterol levels. On the other hand, a negative correlation was observed between sRAGE and Plt in the total, hypertensive and no systemic disease control subgroups. Multivariate logistic regression analysis confirmed that the -374A allele (p < 0.001), hyperlipidemia (p < 0.05), and high sOLR1 level (p < 0.05) are risk factors for CAE. ROC curve analysis shows that RAGE -374A allele has AUC of 0.713 (sensitivity: 83.7 %, specificity: 59.0 %), which is higher than HLD (sensitivity: 59.2 %, specificity: 69.0 %), HT (sensitivity: 62.4 %, specificity: 61.1 %) and high sOLR1 level (≥0.67 ng/ml)) (sensitivity: 59.8 %, specificity: 58.5 %). Conclusion Beside the demonstration of the relationship between -374A allele and increased risk of CAE for the first time, our results indicate that antihypertensive and antidiabetic treatment in CAE patients causes an increase in sRAGE levels. The lack of an association between the expected -374A allele and low sRAGE levels in total CAE group was attributed to the high proportion of hypertensive patients and hence to antihypertensive treatment. Moreover, the RAGE -374A allele is associated with younger age at CAE and higher Plt, suggesting that -374A may also be associated with platelet activation, which plays a role in the pathogenesis of CAE. However, our data need to be confirmed in a large study for definitive conclusions.

Study on the Relationship between Soluble Receptor for Advanced Glycation end Products and Coronary Artery Disease in Nondiabetic Patients

The Relationship Between Soluble Lymphocyte Activation Gene-3 and Coronary Artery Disease

Relationship Between Soluble Receptor of Advanced Glycation End Product and Carotid Atherosclerosis in Patients under Hemodialysis

Study in the relationship between severity of coronary artery disease and high sensitive-C reaction protein as well as insulin resistance

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Association of ABO Blood Groups with the Severity of Coronary Artery Disease: a Cross-Sectional Study

Study Of The Correlation Between Blood Lipid Levels And The Severity Of Coronary Atherosclerosis In A Chinese Population Sample

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Receptor for Advanced Glycation End Products Involved in Circulating Endothelial Cells Release from Human Coronary Endothelial Cells Induced by C-reactive Protein

Coronary Angiographic Studies of Impaired Glucose Regulation and Coronary Artery Disease in Chinese Nondiabetic Subjects

Relations Between Plasma Asymmetric Dimethylarginine (adma) and Risk Factors for Coronary Disease

Relationship between C-reactive protein level and angiographical characteristics of coronary atherosclerosis

Clinical Relevance of Cleaved RAGE Plasma Levels As a Biomarker of Disease Severity and Functional Outcome in Aneurysmal Subarachnoid Hemorrhage.

High Sensitive C-reactive Protein, Adiponectin, and Urine Albumin Excretion Rate in Chinese Coronary Artery Disease Patients with Different Glucose Tolerance Status

Correlation Analysis of CML, Srage, and Esrage and the Measure of Atherosclerosis of Coronary Heart Disease

Nonlinear Association of 1,5-Anhydroglucitol with the Prevalence and Severity of Coronary Artery Disease in Chinese Patients Undergoing Coronary Angiography

Hemoglobin A1c and Angiographic Severity with Coronary Artery Disease: A Cross-Sectional Study.

Correlation Between Serum Adiponectin and Severity of Coronary Artery Disease in the Elderly

Receptor for advanced glycation end products polymorphisms in coronary artery ectasia

An Interactive Association of Advanced Glycation End-Product Receptor Gene Four Common Polymorphisms with Coronary Artery Disease in Northeastern Han Chinese

Plasma Ghrelin Levels Are Closely Associated with Severity and Morphology of Angiographically-Detected Coronary Atherosclerosis in Chineses Patients with Diabetes Mellitus